Introduction {#s1}
============

Substantial progress in understanding the genetic contribution to human variation and disease has been made in the past few decades; but the practical application of this knowledge has not met (perhaps exaggerated) expectations \[[@B1]\]. In particular, the increased relative risk of genetic variants for adverse medical conditions in specific populations has been determined through many case/control and population-based cohorts, using candidate gene and genome-wide association (GWA) studies. The population attributable risk, however, of these variants is highly dependent on their allele frequency, in concert with interacting genetic and environmental covariates unique to that population. The population prevalence of these alleles is also critical to the design of further genetic epidemiology studies and consideration of public health screening measures. Most of the current data on population allele frequency (PAF) is derived from relatively small cohorts, focused on major, self-reported ethnic groups, such as the HapMap \[[@B2],[@B3]\] dataset. Larger cohorts have been genotyped for small numbers of genetic variants, again, primarily among the major ethnicities \[[@B4]--[@B6]\]. A consortium comprised of the Institute of Translational Medicine and Therapeutics, the Broad Institute and the Candidate Gene-Association Resource (CARe) led the development of a 50K SNP, custom genotyping microarray (the "IBC array"). This array focuses on candidate genes and pathways with demonstrated influence on inflammatory pathways, metabolic phenotypes and the pathophysiology of cardiovascular disease (CVD). The present study utilizes genotypes from the IBC CARe microarray obtained from the control arm (N=216) of a pre-eclampsia study among an American Indian population in the northern plains of the United States. Population prevalences were determined and compared with HapMap Caucasian and other PAFs. Bioinformatics software was then used to parse the SNPs into functionally related groups and these groups were searched for functionalities that exhibit significant group differences in PAF.

Methods {#s2}
=======

Ethics Statement: Approval was obtained from both the Aberdeen Area Indian Health Service (IHS) and University of North Dakota Institutional Review Boards and the tribal government. Individual, written informed consent was obtained from each participant. The data raw cannot be deposited to a public repository, in accordance with the requirements of our Institutional Review Board and in order to protect participant privacy. However, this data will be made available upon request to qualified researchers for analyses consistent with our consents.

The basis for this analysis are genotypes solely from controls recruited for a Turtle Mountain Community College (TMCC) study of pre-eclampsia between 8/04 and 7/12 \[[@B7]\]. The federally funded IHS, through the hospital and clinic located in Belcourt, North Dakota, is the primary health care provider for eligible tribal members of the Turtle Mountain Band of Chippewa. Controls were identified by automated query of an electronic medical record database (the Resource, Patient, Management System \[RPMS\]) at this facility, using a relevant group of ICD9 codes. Two controls were ascertained by contact of the first individual to deliver before and after the index case. If a potential control declined participation, the woman delivering during the next prior or subsequent day was contacted; and this was continued until two controls were recruited. This method of recruiting controls provides a relatively unbiased, population-based sample.

Template DNA was collected and processed using salivary samples and the Oragene (DNA Genotek Inc) system. Genotyping of the anonymized samples was accomplished by microarray analysis on the IBC (version 1) microarray at The Children's Hospital of Philadelphia. SNPs genotyped are listed at the IBC Array website \[[@B8]\]. Quality control standards were monitored with the mean call rate above 98% for all SNPs on the microarray and less than 4% of samples had a SNP call rate below 95%.

Results of the microarray genotyping will be available to qualified investigators with assurances that 1) no attempts will be made to identify individuals, 2) goals of the analysis are within the scope of the consent and not for anthropologic research, and 3) the results will not be used for commercial purposes.

During initial data analysis a correlation was noted between the PAF of a subset (13.1%) of SNPs and (100 -- PAF) of the comparison population. This was persisted after careful attention to possible inconsistencies between strand designation for the IBC microarray and the NCBI standard reference allele. Strand conversion was suspected as the cause and elimination of all SNPs consisting of GC and/or AT pairs corrected this situation.

HapMap (phases II + III) Caucasian (CEU) and Han Chinese, Denver (CHD) autosomal allele frequencies of the IBC SNPs were obtained from the HapMap website \[[@B9]\]. Allele frequencies for the present study were calculated by counting all available genotypes for a SNP and 95% confidence intervals were calculated as the mean PAF +/- 1.96\* (√((PAF)\*(1-PAF)/(total number of alleles)) to give the upper and lower bounds. For PAFs at the margins of the distribution (i.e. 0-1% or 99-100%), the normal approximation to the binomial distribution is not applicable; as irrational results, such as a lower 95% CI of 100% for a PAF of 100% are obtained. For this reason, the upper confidence intervals were set at 1% for a mean of 0% and the lower confidence interval 99% when the mean was 100%. The 1% value was arrived at by observing that typical estimated PAFs of 99% had lower 95% CIs about 1% less than the mean.

Allele frequencies from two populations were designated significantly different if the upper and lower 95% confidence intervals did not overlap. The median HapMap sample size was 112 individuals or 224 alleles (mean = 186 alleles), whereas the median sample size was 216, or 432 alleles (mean = 424 alleles) for the TMCC cohort.

To assess the potential impact of non-Indian admixture on these findings, Multidimensional Scaling (MDS) analysis was performed using PLINK *v 1.07* \[[@B10]\]. At the SNP level, quality control was performed and SNPs with genotype call rate ≥0.95, a minor allele frequency ≥0.1, and a p-value from the Hardy-Weinberg equilibrium test ≥10^-6^ were kept. A composite score of the three principal components from this analysis was used to dichotomize the population into those most closely related to CEU and those least related to CEU, which is the ethnic group in closest genetic proximity to this American Indian population. The proportion of SNPs with statistically significant PAFs was then determined for these two groups in the same fashion as described above. See [Figure S1](#pone.0075080.s001){ref-type="supplementary-material"} for a graphic representation.

The National Institute of Allergy and Infectious Disease bioinformatic website, Database for Annotation, Visualization and Integrated Discovery (DAVID) v 6.7 \[[@B11],[@B12]\], operating under the "highest" classification stringency, was used to categorize the functionality of the 34,240 TMCC SNPs into 53 groups. Within these groups, the number of SNPs with statistically significant differences in PAF was analyzed using the Excel binomial distribution function and the average number of SNPs with differing PAFs among those included in the groups (47.1%). The probability of finding a group with this number of differing PAFs was evaluated considering the Bonferroni correction for multiple tests, which gives a nominal p value of 0.05/53 = 0.000943. The most typical function of those groups with fewer or more differing PAFs was determined with assistance from the GeneCards \[[@B13]\] website and search for common terms in the "aliases and descriptions" notation for each gene.

Statistical analysis was primarily carried out using SPSS version 10.1.0 software. Descriptive statistics report mean (+/- SD) for continuous variables and proportions with 95% CI for discrete variables. Statistical significance was set at p[\<]{.ul}0.05.

Results {#s3}
=======

Demographic characteristics of the 216 females genotyped include means (SD) of 23.75 (5.47) years, 27.56 (6.72) Kg/m^2^, 12.24 (2.21) years of age, body mass index (BMI) and education respectively. The proportion of current smokers was 46.5% (38.4%-54.7%). The HapMap CEU sample is from Utah residents with Northern and Western European ancestry; and the HapMap CHD population is from Chinese residents in metropolitan Denver, Colorado. The proportion of PAFs in various ranges in this American Indian population is shown in [Figure 1](#pone-0075080-g001){ref-type="fig"}.

![The proportion of PAFs in ranges for TMCC and HapMap populations.](pone.0075080.g001){#pone-0075080-g001}

A plot of PAFs from the HapMap CEU population vs the TMCC population is seen in [Figure 2](#pone-0075080-g002){ref-type="fig"}. Of the 34,240 SNPs that could be compared with the HapMap CEU prevalence, allele frequencies among this American Indian population were respectively 9.8%, 37.2% and 47.1% significantly greater, lesser or either. The analogous results for a comparison of Denver Han Chinese with this cohort shows 65.0%, 24.4% and 89.4% significantly greater, lesser or either. The distribution of differing PAFs between these three populations, stratified by range of American Indian PAFs, is given in [Figure 3](#pone-0075080-g002){ref-type="fig"}. In the range of TMCC PAFs between 20 and 80%, there were 18,451 SNPs that could be compared with HapMap CEU and 54.7% and 16.4% showed absolute differences of 10% and 20%, respectively.

![Plot of TMCC vs HapMap CEU PAFs.](pone.0075080.g002){#pone-0075080-g002}

![The number of SNPs in each TMCC prevalence range with a statistically significant different PAF than HapMap CEU or CHD MAFs.](pone.0075080.g003){#pone-0075080-g003}

To evaluate the possible influence of admixture in this population, comparisons were made between the two partitioned halves of the American Indian population (more and less closely related to Europeans) and the HapMap CEU population. This analysis resulted in lessening of the proportion of differing PAFs (partly related to loss of power from reduced population size), such that 12.4% of those most closely related to Europeans had statistically different PAFs, compared with 23.9% of those less closely related.

Comparisons between the three other reports of population-based PAFs among those of European ethnicity and this American Indian cohort are shown in [Table 1](#tab1){ref-type="table"}. Of the 92 PAFs that could be compared between these populations and the TMCC cohort, a total of 71 (77.1%) were significantly different; and even 4 of the 7 SNPs (57%) that allowed pair-wise comparisons among 3 European cohorts themselves showed a significant difference ([Table 1](#tab1){ref-type="table"}).

###### Comparisons between TMCC and European PAFs reported in the literature.

  NHANES \[4\] vs TMCC                                                                                
  ----------------------------------------------- ----- ------- ------- ------- ------- ------- ----- ------
  Total SNPs                                      1     3       1       10      14      9       0     38
  Differing                                       0     1       1       7       12      7       0     28
  \% of Total                                     0.0   33.0    100.0   70.0    85.7    77.7    0.0   73.7
  Cross et al. \[6\] (European) vs TMCC                                                               
  Total SNPs                                      0     1       4       11      8       3       0     27
  Differing                                       0     1       2       9       6       3       0     21
  \% of Total                                     0.0   100.0   50.0    81.8    75.0    100.0   0.0   77.7
  Cross et al. \[6\] (American Indian) vs TMCC                                                        
  Total SNPs                                      0     1       4       11      8       3       0     27
  Differing                                       0     1       4       7       5       2       0     19
  \% of Total                                     0.0   100.0   100.0   63.6    62.5    66.6    0.0   70.3
  Huang et al. \[5\] vs TMCC                                                                          
  Total SNPs                                      0     2       3       5       13      4       0     27
  Differing                                       0     2       2       5       9       4       0     22
  \% of Total                                     0.0   100.0   66.6    100.0   69.2    100.0   0.0   81.5
  Huang et al vs Cross vs NHANES[\*](#ngtab1.1)                                                       
  Total SNPs                                      0     0       0       4       2       1       0     7
  Differing                                       0     0       0       1       2       1       0     4
  \% of Total                                     0.0   0.0     0.0     25.0    100.0   100.0   0.0   57.1

Note this last comparison is for any one of the 3 literature reports that differs from one of the others

Using the "highest" stringency criteria, there were 705 DAVID identified genes associated with 8,921 SNPs among the 53 functional groups detected. [Table 2](#tab2){ref-type="table"} shows these 53 groups, the number of SNPs assigned to each ranged from 2 to 972 with a mean of 168. The number of differing PAFs in each group and the binomial probability of that number (or more extreme values) are shown in [Table 2](#tab2){ref-type="table"}. While none of the groups reach a Bonferroni corrected p value of 0.00094, in total there were 7 of these 53 groups with either more or less than expected numbers of differing PAFs. With a nominal p value of 0.05, one would expect fewer than 5 out of 53, and the finding of 7 has an overall probability of 0.0046. There were 28 of the 53 groups with more differing PAFs, compared with 25 groups with less. Assuming an equal distribution of "more" and "less" groups, this is an unremarkable distribution (p=0.392).

###### Functional groups with significantly increased numbers of PAFs differing from HapMap CEU.

  GROUP   TOTAL SNPs   DIFFERING   DAVID GENES   PROBABILITY[\*](#ngtab2.1)   DIRECTION[\*\*](#ngtab2.2)
  ------- ------------ ----------- ------------- ---------------------------- ----------------------------
  2       70           38          12            0.0928                       MORE
  5       130          67          15            0.1353                       MORE
  6       100          49          12            0.3149                       MORE
  7       144          49          7             0.0010                       LESS
  8       834          378         93            0.1604                       LESS
  9       76           31          6             0.1618                       LESS
  10      84           45          9             0.0973                       MORE
  11      16           9           7             0.3140                       MORE
  12      40           17          5             0.3368                       LESS
  14      367          159         31            0.0810                       LESS
  15      65           27          6             0.2199                       LESS
  17      62           34          5             0.0889                       MORE
  18      49           25          6             0.2439                       MORE
  19      145          65          12            0.3215                       LESS
  20      94           40          7             0.2181                       LESS
  21      105          38          5             0.0156                       LESS
  22      50           24          9             0.3931                       MORE
  23      91           36          6             0.0904                       LESS
  24      72           40          5             0.0600                       MORE
  25      107          48          13            0.3574                       LESS
  26      50           20          8             0.1941                       LESS
  27      84           43          12            0.1947                       MORE
  28      18           14          5             0.0018                       MORE
  29      343          147         15            0.0640                       LESS
  30      551          254         18            0.3344                       MORE
  31      75           32          5             0.2573                       MORE
  32      551          266         27            0.2756                       MORE
  33      628          301         62            0.3238                       MORE
  34      334          172         25            0.0481                       MORE
  35      143          82          10            0.0056                       MORE
  36      31           20          6             0.0166                       MORE
  37      25           10          11            0.3062                       LESS
  39      93           46          13            0.2873                       MORE
  40      423          184         10            0.0754                       LESS
  41      60           30          5             0.2808                       MORE
  42      71           37          6             0.1672                       MORE
  44      32           17          8             0.1949                       MORE
  46      83           34          9             0.1562                       LESS
  47      104          40          23            0.0472                       LESS
  49      16           8           6             0.3140                       LESS
  50      37           21          6             0.0899                       MORE
  52      99           42          32            0.2031                       LESS
  53      41           14          5             0.0651                       LESS

Limited to those 43 with probability less than 0.35 of 53 groups in total.

Probability of this number (or more extreme comparisons) of SNP PAFs "Differing" out of the total, given an "a priori" probability of 0.471 for a "Differing" SNP PAF.

MORE indicates an excess of PAFs differing between the populations and LESS means there was a relative deficit of PAFs differing between the populations.

The genes identified in the 7 groups with more or less than expected numbers of differing PAFs are listed in [Table 3](#tab3){ref-type="table"}. Those groups with decreased numbers of differing PAFs included the genes for the collagen structural proteins, and genes coding for transmembrane proteins and the Kell blood group. Groups with increased numbers of differing PAFs included one with influence on glucose metabolism; one involved with immune function, and a group related to drug and metabolic detoxification pathways.

###### Characteristics of 7 Gene Groups showing significantly more or less SNPs with differing prevalences.

  -------------------------------------------------------------------------- ---------- ---------- ---------- ----------- -----------
  Group 7 (collagen), p=0.0010 LESS                                                                                       
  COL6A2                                                                     COL4A5     COL9A2     COL4A2     COL4A1      COL4A6
  Group 28 (insulin regulation, IGF1R), p=0.0018 MORE                                                                     
  EIF2B1                                                                     EIF2B3     EIF2B4     EIF2B5     EIF2B2      
  Group 35 (immune response, T-cell signaling), p=0.0056 MORE                                                             
  NFATC4                                                                     REL        TFAP2B     NFATC3     NFATC1      SOX5
  NFAT5                                                                      NFATC2     FOXJ2      NFE2L2                 
  Group 21 (collagen), p=0.0156, LESS                                                                                     
  COL3A1                                                                     COL1A2     COL1A1     COL5A2     COL5A1      
  Group 36 (dual specificity phosphatase, Erk/JNK pathway), p=0.0166, MORE                                                
  DUSP9                                                                      DUSP7      DUSP10     DUSP5      DUSP6       DUSP2
  Group 47 (transmembrane proteins, Kell blood group), p=0.0472, LESS                                                     
  TSPAN31                                                                    TMEM61     TMEM132E   TMEM63A    CD53        PRRT1
  ARMC10                                                                     SMCR7      TMEM132D   MS4A6A     PDZK1IP1    C10orf72
  MUSTN1                                                                     STARD3NL   ARV1       C12orf23   C14orf101   C14orf118
  HAS3                                                                       EVC        XKR6       KIAA2013   CCDC109B    
  Group 34 (cytochrome P450, drug metabolism), p=0.0481, MORE                                                             
  CYP4A11                                                                    CYP27A1    CYP2D6     CYP2E1     CYP2C9      TBXAS1
  CYP3A4                                                                     CYP8B1     CYP7A1     CYP2J2     CYP4F2      CYP1A2
  CYP2C19                                                                    CYP26A1    CYP7B1     CYP17A1    CYP2A6      CYP4B1
  CYP3A5                                                                     CYP19A1    CYP1B1     CYP2A7     CYP2C18     CYP2C8
  -------------------------------------------------------------------------- ---------- ---------- ---------- ----------- -----------

Discussion {#s4}
==========

Population-based allelic prevalences are critical data for the integration and implementation of novel genetic findings into clinical and public health efforts, as well as furthering future genetic epidemiology investigations. The present report provides the most extensive data on PAFs within an American Indian population, both in terms of the very large number of SNPs genotyped (over 34,000) and the relatively large number of individuals genotyped (216). The value of this resource is enhanced by the fact that the basis of the identified ethnicity relies on official, legally maintained records dating back multiple generations, rather than self-reported ethnicity, as in most other studies.

For reasons that are unclear, there appears to be an increased number of monomorphic SNPs in the HapMap populations, as seen in [Figure 1](#pone-0075080-g001){ref-type="fig"}. The fact that over twice as many alleles were genotyped for the TMCC population creates an increased power to detect low allele frequencies and hence a decreased likelihood of monomorphic SNPs. It seems unlikely however, that this would produce the large difference between populations in proportion of SNPs that are monomorphic.

These data show a considerable degree of variation between majority and minority populations in overall SNP prevalence, even when comparing that portion of the American Indian population most closely related to Europeans. This is consistent with reports of differing (by arbitrary absolute values) PAFs of 22% \[[@B4]\] and 33% \[[@B5]\] between African American and Caucasian groups, and a somewhat smaller proportion (7.8%) comparing Caucasian and Mexican Americans. Garte et al. \[[@B14]\] have reported a similar degree of differing PAFs among two metabolic gene SNPs in Japan versus Korea and Singapore. An extensive genome-wide association study \[[@B15]\] of body mass index (BMI) among 1,120 Pima Indian participants, ascertained largely through familial relationships, used an over 900,000 SNP microarray but found a high rate (35%) of PAFs \< 5%. In addition, one SNP with strong genome-wide association in the European population \[[@B16]\] and a PAF of 21% was monomorphic in this Pima population. This clearly illustrates the powerful effect of variant allele frequencies on both study design and population attributable risk.

Even in a very large Caucasian cohort with self-reported ancestral region of origin, there were still 19 of 51 SNPs (37%) with statistically differing PAFs \[[@B6]\]. The current analysis of three populations of self-identified Caucasian Europeans, showed a surprisingly high proportion (4/7, 57.1%) of pair-wise comparisons with differing PAFs.

It must be recognized, however, that the demonstration of statistically significant differences between populations using large sample sizes and very precise estimates does not translate into clinically (or public health related) important differences in PAF. Still, absolute differences in PAF of 10% and 20% between CEU and this American Indian cohort were found in 54.7% and 16.4% of SNPs, respectively. This provides cautionary information for those who may place undue confidence in the similarity of standard "ethnicities", especially those which are self-reported.

When considering SNPs from functionally related genes, we see that 7 groups showed excessive or reduced numbers of differing PAFs and that this distribution of groups with a p value less than 0.05 is highly unusual (p=0.0046). The presence of fewer differing PAFs could be due to selection pressure since two of the three groups coded for collagen, which may well be under selection constraints. The groups with more differing PAFs could be explained by genes with minimal selection pressure or a founder effect.

The functionality of those groups with fewer differing PAFs seemed more related to basic physiologic mechanisms, such as the structural collagen genes and certain of the transmembrane proteins, possibly involved in signaling. This naturally suggests that these critical functions may be more affected by selection pressure at the species level, and require more uniformity and representation of these SNPs. Those with more differing PAFs involved immune response, detoxification metabolism and glucose metabolism. The latter is of particular interest given the increased prevalence of diabetes in many American Indian populations \[[@B17]\].

This study would clearly be strengthened if a greater number of genotypes were available for both the American Indian and HapMap PAFs, but the countervailing strength of both these sources is the very large number of SNPs available for analysis (tens of thousands) in contrast to the only other analyses with thousands of genotypes on tens of SNPs. The other strength of the present report is the use of objective, carefully maintained, records of ethnic origin, rather than self-reported ethnicity. The only other report of population-based American Indian PAFs genotyped only 51 SNPs among 167 individuals of self-reported ethnicity \[[@B6]\].

In conclusion, these results from a very large number of SNPs genotyped in a substantial number of American Indian participants, ascertained in a population-based manner show that a high proportion of SNP population allele frequencies differ from those reported in Caucasians from the HapMap dataset. There also appear to be groups of genes with certain functionalities which have significantly more or less differing PAFs. These results will be useful in the design of future genetic epidemiology studies and may eventually find utility in public health or clinical screening efforts.
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###### Plot of Principal Components 1 vs 2, showing dichotomized TMCC population and selected comparison populations.
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